Welcome to LookChem.com Sign In|Join Free
  • or
Benzene, 1,1',1''-[[(2S)-3-(hexadecyloxy)-2-(5-hexenyloxy)propoxy]methylidyne]tris - is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

431063-05-7

Post Buying Request

431063-05-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

431063-05-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 431063-05-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,1,0,6 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 431063-05:
(8*4)+(7*3)+(6*1)+(5*0)+(4*6)+(3*3)+(2*0)+(1*5)=97
97 % 10 = 7
So 431063-05-7 is a valid CAS Registry Number.

431063-05-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-hexadecyloxy-2-(5'-hexenyloxy)-sn-3-trityloxypropane

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:431063-05-7 SDS

431063-05-7Relevant academic research and scientific papers

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

-

Page 16, (2008/06/13)

Novel synthetic forms of etherified oxidized phospholipids and methods of utilizing same for preventing and treating atherosclerosis and other related disorders, as well as inflammatory disorders, immune mediated diseases, autoimmune diseases and proliferative disorders, are provided. In addition, methods of synthesizing etherified and esterified oxidized phospholipids and of using same for preventing and treating atherosclerosis and other related disorders are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 431063-05-7